Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey


Erdogan A., Karaman M. G. , Ozdemir E., Yurteri N., Tufan A. E. , Kurcer M. A.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, vol.20, no.5, pp.407-413, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 5
  • Publication Date: 2010
  • Doi Number: 10.1089/cap.2009.0113
  • Title of Journal : JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
  • Page Numbers: pp.407-413

Abstract

Objective: Risperidone is a promising agent for the treatment of schizophrenia, Tourette's disorder, mood disorders, and disruptive behavior disorders in young populations. However, adverse effects of risperidone may take a long time to emerge. The objective of this study was to investigate the changes in the liver function tests (LFTs) associated with more than 6 months of risperidone treatment in children and adolescents.